DE60130145D1 - Stabile t3 zusammensetzungen und ihre anwendung - Google Patents

Stabile t3 zusammensetzungen und ihre anwendung

Info

Publication number
DE60130145D1
DE60130145D1 DE60130145T DE60130145T DE60130145D1 DE 60130145 D1 DE60130145 D1 DE 60130145D1 DE 60130145 T DE60130145 T DE 60130145T DE 60130145 T DE60130145 T DE 60130145T DE 60130145 D1 DE60130145 D1 DE 60130145D1
Authority
DE
Germany
Prior art keywords
stable
patient
compositions
application
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130145T
Other languages
English (en)
Other versions
DE60130145T2 (de
Inventor
Manhasset Klein
Manhasset Ojamaa
Leo Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resuscitation Technologies LLC
Original Assignee
Resuscitation Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resuscitation Technologies LLC filed Critical Resuscitation Technologies LLC
Publication of DE60130145D1 publication Critical patent/DE60130145D1/de
Application granted granted Critical
Publication of DE60130145T2 publication Critical patent/DE60130145T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60130145T 2000-12-21 2001-11-30 Stabile t3 zusammensetzungen und ihre anwendung Expired - Lifetime DE60130145T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25766600P 2000-12-21 2000-12-21
US257666P 2000-12-21
US32756901P 2001-03-12 2001-03-12
US79825901A 2001-03-12 2001-03-12
US327569P 2001-03-12
PCT/US2001/044855 WO2002051403A1 (en) 2000-12-21 2001-11-30 Compositions of stable t3 and methods of use thereof

Publications (2)

Publication Number Publication Date
DE60130145D1 true DE60130145D1 (de) 2007-10-04
DE60130145T2 DE60130145T2 (de) 2008-05-15

Family

ID=26946117

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130145T Expired - Lifetime DE60130145T2 (de) 2000-12-21 2001-11-30 Stabile t3 zusammensetzungen und ihre anwendung

Country Status (7)

Country Link
EP (1) EP1351673B1 (de)
JP (3) JP2004525874A (de)
AT (1) ATE370729T1 (de)
CA (1) CA2432523C (de)
DE (1) DE60130145T2 (de)
ES (1) ES2291274T3 (de)
WO (1) WO2002051403A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021009855A2 (pt) 2019-01-09 2021-08-17 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. l-tri-iodotironina para uso no tratamento de obstrução microvascular

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
DE3812609A1 (de) * 1988-04-15 1989-11-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung von thyroxin und dazu geeignete standardloesung
DE4226949A1 (de) * 1992-08-14 1994-02-17 Boehringer Mannheim Gmbh Verfahren und Standardlösung zur Bestimmung von Thyroxin (T¶4¶) oder Trijodthyronin (T¶3¶)
ATE124258T1 (de) * 1990-02-05 1995-07-15 British Tech Group Usa Schilddrüsenhormone zur kardialen behandlung.
JP3895782B2 (ja) * 1992-10-26 2007-03-22 生化学工業株式会社 コンドロイチナーゼ組成物およびそれを含有する注射用製剤
JP2622653B2 (ja) * 1992-12-18 1997-06-18 三洋化成工業株式会社 甲状腺ホルモン水溶液
JPH06213598A (ja) * 1993-01-19 1994-08-02 Mitsubishi Electric Corp 誘導飛翔体
JP3428225B2 (ja) * 1995-04-28 2003-07-22 三菱ウェルファーマ株式会社 ポルフィリン金属錯体−アルブミン包接化合物及び酸素運搬体
US5795789A (en) * 1997-06-04 1998-08-18 Dade Behring Inc. Standard solution for the determination of thyroid function
IL139933A0 (en) * 1998-05-29 2002-02-10 Biogen Inc A liquid composition containing recombinant interferon-beta

Also Published As

Publication number Publication date
ES2291274T3 (es) 2008-03-01
JP2005060409A (ja) 2005-03-10
WO2002051403A1 (en) 2002-07-04
EP1351673A1 (de) 2003-10-15
DE60130145T2 (de) 2008-05-15
CA2432523C (en) 2014-06-03
JP2004525874A (ja) 2004-08-26
EP1351673B1 (de) 2007-08-22
CA2432523A1 (en) 2002-07-04
ATE370729T1 (de) 2007-09-15
JP2009120625A (ja) 2009-06-04

Similar Documents

Publication Publication Date Title
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
ATE289332T1 (de) Silikongel enthaltend salizylsäure
DE60120451D1 (de) Antibakterielle mittel sowie diese enthaltende antibakterielle und deodorierende lösung
TR200001203T2 (tr) Yeni birleşik maddeler
DE69521623D1 (de) Zusammensetzung für die stabilisation von zahnprothesen
TR200000782T2 (tr) Resorsinol türevleri.
DE69433870D1 (de) Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
ES2022883B3 (es) Una composicion desodorante y uso de ella
PT1216707E (pt) Novas utilizacoes terapeuticas para um smr-1-peptideo
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DK1098631T3 (da) Farmaceutisk præparat især beregnet til forebyggelse og behandling af radiomucositis og kemomucositis
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
BR9914644A (pt) Composições tamponadas para diálise
SE9801494D0 (sv) Novel use
SE0004101D0 (sv) New use
DE60130145D1 (de) Stabile t3 zusammensetzungen und ihre anwendung
PT1333797E (pt) Composicoes dentarias para dentes hipersensiveis
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
BR0009194A (pt) Composição do resorcinol
EA200100141A1 (ru) Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.
DK1450616T4 (da) Præparation af krydderurter
DK0633723T3 (da) Anvendelse af iodbrintesyre som et afrodisiakum
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: KLEIN, IRWIN, MANHASSET, NY, US

Inventor name: OJAMAA, KAIE, MANHASSET, NY, US

Inventor name: RUBIN, LEO, SUFFERN, NY 10901, US

8364 No opposition during term of opposition